Leave Your Message
PepAxis-Nova3 Peptide Synthesizer from China Suppliers - High-Quality Factory Product for Efficient Peptide Synthesis
Hot Products

PepAxis-Nova3 Peptide Synthesizer from China Suppliers - High-Quality Factory Product for Efficient Peptide Synthesis

Discover our high-quality products sourced directly from trusted China suppliers. Our factory employs state-of-the-art manufacturing techniques to ensure that every item meets strict quality standards. With a commitment to excellence and innovation, we provide a diverse range of products that cater to various industries. Partner with us to experience the advantage of working with reliable China suppliers, and elevate your business with our exceptional factory offerings

    The Nova 3 (formerly 386 pro) peptide synthesizer is a fully automated intelligent platform designed specifically for multi-task parallel synthesis. The instrument offers flexible configurations with 2, 4, or 6 channels and supports independent parallel or asynchronous synthesis modes. Each channel can simultaneously synthesize peptides with different sequences, scales, and synthesis methods, truly achieving "one machine, multiple uses." Equipped with a high-precision quantitative dispensing system, the instrument ensures accurate reagent dosing. Each channel supports independent configuration of synthesis parameters (such as activation method, reaction time, and deprotection time), significantly enhancing synthesis flexibility.

    ⚙️

    Flexible Channel Configuration

    Available in 2, 4, or 6 channel setups to match your throughput requirements.

    🔀

    Parallel & Asynchronous Modes

    Run independent or asynchronous synthesis across all channels simultaneously.

    🎯

    High-Precision Dispensing

    Quantitative dispensing system ensures accurate and reproducible reagent dosing.

    🧬

    Independent Parameter Control

    Each channel supports custom activation method, reaction time, and deprotection time.

    Nova 3 Peptide Synthesizer
    • Parallel Preparation of Multiple Sequences
    • Peptide Drug Screening
    • Structure-Activity Relationship Studies
    • Peptide Library Construction
    Frequently Asked Questions
    Q What channel configurations are available for the Nova 3 peptide synthesizer?
    The Nova 3 is available in 2, 4, or 6 channel configurations, allowing laboratories to select the setup that best matches their throughput and workflow requirements.
    Q Can each channel synthesize different peptide sequences at the same time?
    Yes. Each channel on the Nova 3 operates independently and can simultaneously synthesize peptides with entirely different sequences, scales, and synthesis methods — enabling true multi-task parallel synthesis in a single run.
    Q What synthesis parameters can be independently configured per channel?
    Each channel allows independent configuration of key synthesis parameters including the activation method, reaction time, and deprotection time. This flexibility ensures optimized conditions for each individual peptide being synthesized.
    Q What is the difference between parallel and asynchronous synthesis modes?
    In parallel mode, all channels run the same synthesis steps simultaneously. In asynchronous mode, each channel operates on its own independent schedule and cycle, allowing channels to be at different synthesis stages at any given time — maximizing instrument utilization and flexibility.
    Q What are the primary applications of the Nova 3 synthesizer?
    The Nova 3 is ideally suited for cutting-edge research applications including parallel preparation of multiple peptide sequences, peptide drug screening, structure-activity relationship (SAR) studies, and peptide library construction.
    Q How does the high-precision dispensing system benefit synthesis accuracy?
    The integrated high-precision quantitative dispensing system precisely controls the volume of each reagent delivered to every channel. This minimizes dosing errors, improves reproducibility across batches, and ensures consistent synthesis outcomes — especially critical for drug screening and library preparation workflows.